---
title: "KOO JAKAP — Ownership Dossier"
canonical: https://whiteintel.dev/entity/dc6e7ca4-e06d-59c0-97a9-2312b36f747b
json: https://whiteintel.dev/api/public/dossier/dc6e7ca4-e06d-59c0-97a9-2312b36f747b
identifier: sec:0002041972
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# KOO JAKAP

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002041972`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/dc6e7ca4-e06d-59c0-97a9-2312b36f747b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/dc6e7ca4-e06d-59c0-97a9-2312b36f747b  

## Ownership & control

### Holdings / subsidiaries

- **APIMEDS PHARMACEUTICALS US, INC.** (director) — https://whiteintel.dev/entity/688fba43-8575-510d-b3da-df6554f94ffd

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KOO JAKAP**. Human view: https://whiteintel.dev/entity/dc6e7ca4-e06d-59c0-97a9-2312b36f747b · Structured JSON: https://whiteintel.dev/api/public/dossier/dc6e7ca4-e06d-59c0-97a9-2312b36f747b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._